Allianz Asset Management Gmb H Bridge Bio Pharma, Inc. Transaction History

Allianz Asset Management Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$7.17 - $18.55 $151,287 - $391,405	21,100 New	21,100 $349,000
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $92,519 - $434,223	-8,130 Reduced 19.66%	33,228 $554,000
Q3 2021 Nov 10, 2021	SELL	$46.87 - $64.24 $135,923 - $186,295	-2,900 Reduced 6.55%	41,358 $1.94 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $644,074 - $886,069	-13,860 Reduced 23.85%	44,258 $2.7 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $1.65 Million - $2.15 Million	29,658 Added 104.21%	58,118 $3.58 Million
Q3 2020 Nov 13, 2020	SELL	$27.2 - $42.19 $69,360 - $107,584	-2,550 Reduced 8.22%	28,460 $1.07 Million
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $549,922 - $883,291	-24,749 Reduced 44.39%	31,010 $1.01 Million
Q1 2020 May 14, 2020	SELL	$16.11 - $36.23 $408,179 - $917,959	-25,337 Reduced 31.24%	55,759 $1.62 Million
Q4 2019 Feb 13, 2020	BUY	$17.96 - $46.63 $1.46 Million - $3.78 Million	81,096 New	81,096 $2.84 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.